JB
Justin B. Klee
Co-CEO & DirectorMr. Justin B. Klee co-founded Amylyx Pharmaceuticals, Inc. in 2013 and has been its Co-Chief Executive Officer and Director since January 2014. Mr. Klee served as President of Amylyx Pharmaceuticals, Inc. Mr. Klee has leveraged his extensive experience in neurophysiology and Alzheimer ’s disease research to help build and evaluate Amylyx’s novel platform and therapeutic for neurodegenerative diseases. His research includes work at Brown University and Harvard Medical School. Mr. Klee holds B.Sc. in Neuroscience from Brown University.
Positions
- Company NameAmylyx Pharmaceuticals, Inc.Stock CodeAMLXPositionCo-CEO & DirectorColleagues
- JBJoshua B. CohenCo-Founder, Co-CEO & Director
- GMGeorge Mclean MilneIndependent Chairman of the Board
- JMJames M. FratesChief Financial Officer
- CLCamille L. BedrosianChief Medical Officer
- THTom HolmesChief Technical Operations Officer
- RERudolph Emile TanziChairman of The Scientific Advisory Board
- PRPaul R. FonteyneIndependent Director
